Results 61 to 70 of about 6,415,892 (312)

Advances in Parkinson’s Disease Drugs [PDF]

open access: yes, 2021
Parkinson’s disease (PD) is the second most common neurodegenerative age-related disorder worldwide after Alzheimer’s disease [...
Lisa Marinelli   +3 more
core   +1 more source

Invisible but not inaccessible—Revealing transient oligomers formed by intrinsically disordered proteins with solution NMR and complementary methods

open access: yesFEBS Letters, EarlyView.
Transient oligomers formed by intrinsically disordered proteins may be ‘invisible’ to direct detection yet remain accessible to solution NMR through equilibrium‐exchange measurements and pressure‐jump experiments. Complementary methods report on mass, stoichiometry, selected distance distributions, morphology, and internal packing.
Martin D. Gelenter, Ad Bax
wiley   +1 more source

Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles

open access: yeseLife
The alpha-synuclein (αSyn) seeding amplification assay (SAA) that allows the generation of disease-specific in vitro seeded fibrils (SAA fibrils) is used as a research tool to study the connection between the structure of αSyn fibrils, cellular seeding ...
Selene Seoyun Lee   +2 more
doaj   +1 more source

MOESM2 of Prevalence and incidence of Parkinsonâ s disease and drug-induced parkinsonism in Korea

open access: yes, 2019
Additional file 2: Figure S1. Sensitivity analysis. Incidence of drug-induced parkinsonism in Korea.
Han, Sola   +5 more
openaire   +1 more source

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

open access: yes, 2023
Although over 90 independent risk variants have been identified for Parkinson’s disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale multi-ancestry meta-analysis
the 23andMe Research Team; the Global Parkinson’s Genetics Program (GP2)   +11 more
core   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

open access: yesMolecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau   +9 more
wiley   +1 more source

Brain insulin resistance as a driver of proteinopathy in neurodegeneration: from cell-type-specific mechanisms to targeted therapeutics

open access: yesTranslational Neurodegeneration
Neurodegenerative diseases are increasingly linked to systemic metabolic dysfunction, with brain insulin resistance (BIR) positioned as a central mediator. Yet translating this insight into effective therapies has proven remarkably difficult. This review
Man Xiang   +6 more
doaj   +1 more source

Pramipexole alleviates non-motor symptoms and autophagy-related protein abnormalities in a dual neurotoxin Parkinson’s disease model

open access: yesBrain Research Bulletin
Parkinson's disease (PD) is characterized by motor deficits and debilitating non-motor symptoms (NMS), including depression, anxiety, and cognitive impairment.
Shimin Pang   +9 more
doaj   +1 more source

Additional file 2: of LRRK2 contributes to monocyte dysregulation in Parkinsonâ s disease

open access: yes, 2019
LRRK2 protein expression is significantly upregulated in monocytes from PD patients. (PDF 303 kb)
Bliederhaeuser, Corinna   +11 more
openaire   +1 more source

Retraining function in people with Parkinson’s disease using the Microsoft kinect: game design and pilot testing [PDF]

open access: yes, 2010
Human centred and co-design approaches to designing often involve working in collaborative, multi-disciplinary contexts. In such situations promoting collegial and open environments and methods of engagement to bring forward and capture the ideas ...
Sherringham, SJ   +23 more
core   +1 more source

Home - About - Disclaimer - Privacy